United Therapeutics (UTHR) Market Capitalization (2009 - 2026)

United Therapeutics has disclosed Market Capitalization across 18 years of filings, most recently posting $23.1 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 77.98% year-over-year to $23.1 billion; the TTM figure through Jun 2026 stood at $23.1 billion (up 77.98% YoY), while the FY2025 annual figure was $21.3 billion, up 34.43% from the prior year.
• Market Capitalization came in at $23.1 billion for Q2 2026 at United Therapeutics, down from $25.0 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $25.0 billion in Q1 2026 to a low of $8.1 billion in Q1 2022.
• Average Market Capitalization over 5 years is $14.1 billion, with a median of $12.9 billion recorded in 2022.
• Year-over-year, Market Capitalization declined 19.2% in 2023 and jumped 79.9% in 2026.
• Over 5 years, Market Capitalization stood at $12.8 billion in 2022, then retreated by 19.2% to $10.3 billion in 2023, then soared by 52.93% to $15.8 billion in 2024, then soared by 34.43% to $21.3 billion in 2025, then gained by 8.74% to $23.1 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $23.1 billion in Q2 2026, $25.0 billion in Q1 2026, and $21.3 billion in Q4 2025.